Help patients stay ahead
Know more sooner—providing optimal care and meeting goals
Effectively monitor and manage your patients with diabetes to help them delay or avoid complications with our comprehensive panels. Our testing is aligned with American Diabetes Association (ADA) guidelines, making it easy for you to meet key performance measures keep your patients on track with the recommended type and frequency of testing.1-3
Our panels include:
- Diabetes, Newly Diagnosed and Monitoring Panel
Combines all tests recommended by ADA guidelines into one panel3
- Diabetes, Advancing Chronic Kidney Disease (CKD) Management Panel
Combines all tests recommended by ADA guidelines into one panel for patients with diabetes and stage 3 or 4 CKD3
- Nonalcoholic Fatty Liver Disease (NAFLD) Fibrosis Score Panel
Identifies diabetes patients who are at risk for developing serious liver disease (fibrosis score calculated at no additional cost)
Let us help you know what’s ahead
Contact a Quest Diagnostics sales representative to learn more
Want to learn more about the NAFLD Fibrosis Score Panel?
1 Standards of Medical Care in Diabetes—2014. Diabetes Care. 2014;37 (suppl 1):S14-S80. Page S42-S43.
2 National Committee for Quality Assurance. What is the current state of quality of care in diabetes? Available at:
WhatistheCurrentStateofQualityofCare.aspx. Accessed October 27, 2016.
3 Medicare.gov. Star ratings. Available at www.medicare.gov/find-a-plan/staticpages/rating/planrating-help.aspx.
Accessed July 18, 2018.